Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula (right eye)
ICD-10 E10.3531 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula (right eye).
E10.3531 refers to a specific complication of Type 1 diabetes mellitus characterized by proliferative diabetic retinopathy (PDR) that has led to traction retinal detachment in the right eye, without involvement of the macula. Proliferative diabetic retinopathy is a severe form of diabetic eye disease where new, abnormal blood vessels grow on the retina, which can lead to vision loss. The traction retinal detachment occurs when these new vessels pull on the retina, causing it to detach from the underlying tissue. This condition is particularly concerning as it can lead to significant visual impairment if not treated promptly. Management typically involves monitoring blood glucose levels, maintaining HbA1c levels below 7% to prevent further complications, and may require surgical intervention to repair the detachment. Insulin management is crucial for patients with Type 1 diabetes, as it directly influences blood glucose control and, consequently, the risk of developing diabetic complications such as retinopathy.
Detailed examination findings, imaging results, and treatment plans for retinal detachment.
Patients presenting with vision changes, floaters, or flashes of light due to retinal detachment.
Ensure clear documentation of the type of retinal detachment and its relation to diabetic retinopathy.
Comprehensive diabetes management records, including insulin regimen and HbA1c levels.
Patients with poorly controlled diabetes presenting with complications.
Document the impact of diabetes management on ocular health.
Used for treatment of proliferative diabetic retinopathy.
Document the extent of treatment and follow-up care.
Ophthalmology should ensure clear documentation of the procedure and its indications.
Specifying the eye affected is crucial for treatment planning and for understanding the extent of the disease, as management may differ based on whether one or both eyes are involved.
